Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 1905
TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347012BDBM347012(US10202388, Compound 11A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347008BDBM347008(US10202388, Compound 10A-2)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347015BDBM347015(US10202388, Compound 13 | US10358451, Compound 10)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347016BDBM347016(US10202388, Compound 14A-4)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347013BDBM347013(US10202388, Compound 11A-2)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347014BDBM347014(US10202388, Compound 14A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347006BDBM347006(US10202388, Compound 9)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347007BDBM347007(US10202388, Compound 10A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347020BDBM347020(US10202388, Compound 26A | US10202388, Compound 23...)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347018BDBM347018(US10202388, Compound 25 | US10202388, Compound 21)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347033BDBM347033(US10202388, Compound 45A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347022BDBM347022(US10202388, Compound 26A-3 | US10202388, Compound ...)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347019BDBM347019(US10202388, Compound 22)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347020BDBM347020(US10202388, Compound 26A | US10202388, Compound 23...)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347018BDBM347018(US10202388, Compound 25 | US10202388, Compound 21)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347023BDBM347023(US10202388, Compound 23A-3)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347021BDBM347021(US10202388, Compound 23A-1)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347044BDBM347044(US10202388, Compound 62A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347043BDBM347043(US10202388, Compound 61A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347036BDBM347036(US10202388, Compound 46)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347037BDBM347037(US10202388, Compound 49)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347034BDBM347034(US10202388, Compound 45A-1)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347040BDBM347040(US10202388, Compound 53A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347041BDBM347041(US10202388, Compound 55)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347038BDBM347038(US10202388, Compound 52A)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 346998BDBM346998(US10202388, Compound 1-2)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 346999BDBM346999(US10202388, Compound 1-3)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 346996BDBM346996(US10202388, Compound 1)
Affinity DataIC50: 100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347011BDBM347011(US10202388, Compound 10B)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347013BDBM347013(US10202388, Compound 11A-2)
Affinity DataIC50: 300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347042BDBM347042(US10202388, Compound 58)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347034BDBM347034(US10202388, Compound 45A-1)
Affinity DataIC50: 300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347023BDBM347023(US10202388, Compound 23A-3)
Affinity DataIC50: 300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347022BDBM347022(US10202388, Compound 26A-3 | US10202388, Compound ...)
Affinity DataIC50: 300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347002BDBM347002(US10202388, Compound 3)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347003BDBM347003(US10202388, Compound 4)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347035BDBM347035(US10202388, Compound 45A-4)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347004BDBM347004(US10202388, Compound 7)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347005BDBM347005(US10202388, Compound 8)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347039BDBM347039(US10202388, Compound 52B)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347025BDBM347025(US10202388, Compound 26A-2 | US10202388, Compound ...)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347024BDBM347024(US10202388, Compound 26B | US10202388, Compound 23...)
Affinity DataIC50: 300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347025BDBM347025(US10202388, Compound 26A-2 | US10202388, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347009BDBM347009(US10202388, Compound 10A-3)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347032BDBM347032(US10202388, Compound 40)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347035BDBM347035(US10202388, Compound 45A-4)
Affinity DataIC50: 5.50E+3nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 346997BDBM346997(US10202388, Compound 1-1)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347000BDBM347000(US10202388, Compound 1-4)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347017BDBM347017(US10202388, Compound 14A-1)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Shanghai De Novo Pharmatech

US Patent
LigandChemical structure of BindingDB Monomer ID 347001BDBM347001(US10202388, Compound 2)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: